No abstract available
Publication types
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anthropometry
-
Antineoplastic Agents / adverse effects*
-
Dasatinib / adverse effects
-
Glucose Intolerance / chemically induced*
-
Glucose Intolerance / physiopathology
-
Humans
-
Hyperinsulinism / chemically induced
-
Hyperinsulinism / physiopathology
-
Imatinib Mesylate / adverse effects
-
Insulin / blood
-
Insulin Resistance*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Male
-
Prospective Studies
-
Protein Kinase Inhibitors / adverse effects*
-
Pyrimidines / adverse effects*
Substances
-
Antineoplastic Agents
-
Insulin
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate
-
nilotinib
-
Dasatinib